An overview of Alzheimer's disease and therapeutic potential of natural products via In Silico Approach

Alzheimer's disease (AD) is a prominent neurodegenerative illness that causes perpetual loss of intellectual functioning and is a major contributor to dementia cases globally. As per epidemiological statistics, there are approximately 74.7 million AD patients worldwide. The main signs of AD are mostly forgetfulness of recent events and memory loss. In this review we focused on numerous pathways leading to AD, those are oxidative stress, synaptic loss, neuroinflammation, and accumulation of amyloid plaques and neurofibrillary tangles being the major hallmark for the pathology of AD. Natural Product has proved to be best choice of treatment for AD as they offer fewer negative effects and long-lasting advantages. However, many drugs tend to fail clinical trials so as to minimize this possibility computational methods came into light. In this study we discuss the advantages of Computational methods as they are less cost effective, time saving, speeds up the drug design process, requires less animal testing and high success rate using in silico ADMET predictions, molecular docking and dynamic simulation thus making it an excellent tool. This review summarizes information about Alzheimer disease mechanism and the role of natural products in treatment of AD by using in silico techniques.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-06-30
DOI
https://doi.org/10.5281/zenodo.17198213
Primary Topic
Diverse Scientific and Economic Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An overview of Alzheimer's disease and therapeutic potential of natural products via In Silico Approach

Zenodo (CERN European Organization for Nuclear Research)
Diverse Scientific and Economic Studies
article

An overview of Alzheimer's disease and therapeutic potential of natural products via In Silico Approach

article en

Abstract

Alzheimer's disease (AD) is a prominent neurodegenerative illness that causes perpetual loss of intellectual functioning and is a major contributor to dementia cases globally. As per epidemiological statistics, there are approximately 74.7 million AD patients worldwide. The main signs of AD are mostly forgetfulness of recent events and memory loss. In this review we focused on numerous pathways leading to AD, those are oxidative stress, synaptic loss, neuroinflammation, and accumulation of amyloid plaques and neurofibrillary tangles being the major hallmark for the pathology of AD. Natural Product has proved to be best choice of treatment for AD as they offer fewer negative effects and long-lasting advantages. However, many drugs tend to fail clinical trials so as to minimize this possibility computational methods came into light. In this study we discuss the advantages of Computational methods as they are less cost effective, time saving, speeds up the drug design process, requires less animal testing and high success rate using in silico ADMET predictions, molecular docking and dynamic simulation thus making it an excellent tool. This review summarizes information about Alzheimer disease mechanism and the role of natural products in treatment of AD by using in silico techniques.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 35%
Diverse Scientific and Economic Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

An overview of Alzheimer's disease and therapeutic potential of natural products via In Silico Approach · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS